AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivers, J. M.
Right arrow Articles by Devine, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivers, J. M.
Right arrow Articles by Devine, M. M.
Agricola
Right arrow Articles by Rivers, J. M.
Right arrow Articles by Devine, M. M.

American Journal of Clinical Nutrition, Vol 25, 684-689, Copyright © 1972 by The American Society for Clinical Nutrition, Inc.

Plasma ascorbic acid concentrations and oral contraceptives

Jerry M. Rivers Ph.D.1 and Marjorie M. Devine Ph.D.1

1 From the Department of Human Nutrition and Food, New York State College of Human Ecology, Cornell University, Ithaca, New York 14850

Plasma ascorbic acid and total ascorbic acid concentrations were determined in six subjects, four women who ingested oral contraceptives and two controls, over two and one-half menstrual cycles. The subjects were saturated with ascorbic acid. The cyclic patterns noted in plasma ascorbic acid and total ascorbic acid concentrations in the control subjects indicate that during the high estrogen and luteinizing hormone secretion phases of the cycle, plasma levels are increased. The differences between ascorbic acid (as determined by using 2,6-dichlorophenolindophenol) and total ascorbic acid (as determined by using 2,4-dinitrophenylhydrazine) among the various phases of the cycle were equivalent.

Subjects ingesting oral contraceptives had lower plasma ascorbic acid and total ascorbic concentrations than did the controls. The results suggest that oral contraceptives depress plasma ascorbic acid levels and show that the drugs prevent the sharp increase in plasma ascorbic acid at the time of ovulation.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
R. L Wolf, J. A Cauley, M. Pettinger, R. Jackson, A. Lacroix, M. S Leboff, C. E Lewis, M. C Nevitt, J. A Simon, K. L Stone, et al.
Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. A. Simon and E. S. Hudes
Relation of Ascorbic Acid to Bone Mineral Density and Self-reported Fractures among US Adults
Am. J. Epidemiol., September 1, 2001; 154(5): 427 - 433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by The American Society for Nutrition